Suppr超能文献

在一项比较研究中,人格特质解释了迷幻药使用与较少抑郁之间的关系。

Personality traits explain the relationship between psychedelic use and less depression in a comparative study.

作者信息

Sjöström David K, Claesdotter-Knutsson Emma, Kajonius Petri J

机构信息

Child and Adolescent Psychiatry, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.

Region Skåne, Child and Adolescent Psychiatry, Regional Outpatient Care, Lund University Hospital, Lund, Sweden.

出版信息

Sci Rep. 2024 May 3;14(1):10195. doi: 10.1038/s41598-024-60890-1.

Abstract

Interest in psychedelics is increasing due to the potential for improved mental health and quality of life. However, adverse effects on mental health are still a concern. Personality traits have been suggested to both influence the psychedelic experience and mental health, and even be changed by psychedelic use. The present study describes for the first time a national sample of Swedish psychedelic users (n = 400) compared to a sex and age-matched control-group of non-users (n = 400) regarding mental health variables (depression, insomnia, problematic alcohol and drug use, and dissociation) and personality (Big Five). Data was collected in an online survey including individuals from 16 years of age who had at least one psychedelic experience. The main results reported psychedelic users as less depressed (Patient Health Questionnaire-9; PHQ-9) (d = - 0.29) and having more use of drugs (Drug Use Disorders Identification Test; DUDIT) (d = 1.27). In the Big Five personality traits, openness differed notably (d = 1.72), and the between-group effects in PHQ-9 were explained by lower neuroticism. Our findings reveal that psychedelic users report less depression and higher drug use, and this is partly due to personality traits. These results have implications on how we view psychedelic users and the use of psychedelic drugs.

摘要

由于迷幻药在改善心理健康和生活质量方面的潜力,人们对其兴趣与日俱增。然而,对心理健康的不良影响仍是一个令人担忧的问题。有研究表明,人格特质既会影响迷幻药体验和心理健康,甚至还会因使用迷幻药而发生改变。本研究首次描述了一个瑞典迷幻药使用者的全国性样本(n = 400),并将其与一个性别和年龄匹配的非使用者对照组(n = 400)在心理健康变量(抑郁、失眠、问题性酒精和药物使用以及解离)和人格(大五人格)方面进行了比较。数据通过在线调查收集,调查对象包括16岁及以上且至少有过一次迷幻药体验的个体。主要结果显示,迷幻药使用者的抑郁程度较低(患者健康问卷-9;PHQ-9)(d = -0.29),且药物使用频率更高(药物使用障碍识别测试;DUDIT)(d = 1.27)。在大五人格特质中,开放性存在显著差异(d = 1.72),PHQ-9中的组间效应可由较低的神经质来解释。我们的研究结果表明,迷幻药使用者报告的抑郁程度较低且药物使用频率较高,部分原因在于人格特质。这些结果对我们如何看待迷幻药使用者以及迷幻药的使用具有启示意义。

相似文献

3
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.
Eur Neuropsychopharmacol. 2015 Apr;25(4):483-92. doi: 10.1016/j.euroneuro.2015.01.008. Epub 2015 Jan 16.
4
5
Psychedelic drug use and schizotypy in young adults.
Sci Rep. 2021 Jul 23;11(1):15058. doi: 10.1038/s41598-021-94421-z.
6
The Psychedelic Personality: Personality Structure and Associations in a Sample of Psychedelics Users.
J Psychoactive Drugs. 2021 Apr-Jun;53(2):97-103. doi: 10.1080/02791072.2020.1842569. Epub 2020 Nov 29.
7
Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users.
J Psychoactive Drugs. 2023 Jan-Mar;55(1):30-39. doi: 10.1080/02791072.2022.2039815. Epub 2022 Feb 13.
8
Alternative beliefs in psychedelic drug users.
Sci Rep. 2023 Sep 30;13(1):16432. doi: 10.1038/s41598-023-42444-z.
9
Psychedelics, Personality and Political Perspectives.
J Psychoactive Drugs. 2017 Jul-Aug;49(3):182-191. doi: 10.1080/02791072.2017.1312643. Epub 2017 Apr 26.
10
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.
Psychopharmacology (Berl). 2019 Feb;236(2):731-740. doi: 10.1007/s00213-018-5106-2. Epub 2019 Jan 2.

本文引用的文献

1
Psychedelic therapy in the treatment of addiction: the past, present and future.
Front Psychiatry. 2023 Jun 12;14:1183740. doi: 10.3389/fpsyt.2023.1183740. eCollection 2023.
2
Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021.
Addiction. 2023 Dec;118(12):2449-2454. doi: 10.1111/add.16259. Epub 2023 Jun 7.
3
Therapeutic effect of psilocybin in addiction: A systematic review.
Front Psychiatry. 2023 Feb 9;14:1134454. doi: 10.3389/fpsyt.2023.1134454. eCollection 2023.
4
The association between naturalistic use of psychedelics and co-occurring substance use disorders.
Front Psychiatry. 2023 Jan 10;13:1066369. doi: 10.3389/fpsyt.2022.1066369. eCollection 2022.
5
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.
J Affect Disord. 2023 Feb 1;322:194-204. doi: 10.1016/j.jad.2022.09.168. Epub 2022 Oct 7.
6
Predictors of Psychedelic Experience: A Thematic Analysis.
J Psychoactive Drugs. 2023 Sep-Oct;55(4):411-419. doi: 10.1080/02791072.2022.2129885. Epub 2022 Oct 5.
7
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.
J Psychopharmacol. 2022 Oct;36(10):1100-1117. doi: 10.1177/02698811221116926. Epub 2022 Aug 26.
8
Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCP.
Addiction. 2022 Dec;117(12):3099-3109. doi: 10.1111/add.15987. Epub 2022 Aug 17.
9
Personality stability and change: A meta-analysis of longitudinal studies.
Psychol Bull. 2022 Jul-Aug;148(7-8):588-619. doi: 10.1037/bul0000365. Epub 2022 Jul 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验